INTEC PHARMA LTD JERUSALEM's ticker is NTEC and the CUSIP is M53644148. A total of 20 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $59,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 82,761 | $286,000 | 0.07% |
| Virtu Financial LLC | 66,497 | $229,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 120,816 | $417,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 15,306 | $53,000 | 0.01% |
| HighPoint Advisor Group LLC | 10,000 | $59,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 10,199 | $35,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 961 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,089 | $52,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 46,934 | $162,000 | 0.00% |